A detailed history of Jane Street Group, LLC transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 48,388 shares of PRPH stock, worth $15,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,388
Holding current value
$15,000
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$0.24 - $0.88 $11,613 - $42,581
48,388 New
48,388 $19,000
Q2 2023

Aug 14, 2023

SELL
$7.15 - $9.78 $16,309 - $22,308
-2,281 Reduced 18.23%
10,234 $74,000
Q1 2023

May 15, 2023

BUY
$6.62 - $9.57 $1,655 - $2,392
250 Added 2.04%
12,515 $95,000
Q4 2022

Feb 14, 2023

BUY
$8.78 - $12.47 $107,686 - $152,944
12,265 New
12,265 $118,000
Q3 2019

Nov 14, 2019

SELL
$1.63 - $2.2 $16,661 - $22,488
-10,222 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$2.1 - $3.07 $21,466 - $31,381
10,222 New
10,222 $22,000

Others Institutions Holding PRPH

About ProPhase Labs, Inc.


  • Ticker PRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,024,400
  • Market Cap $4.97M
  • Description
  • ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...
More about PRPH
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.